Key Decisions Approved
1. Employee Stock Option Scheme Approval
The Board of Directors approved the NUKLEUS OFFICE SOLUTIONS LIMITED EMPLOYEE STOCK OPTION SCHEME – I 2026 ("ESOP Scheme") based on the recommendation of the Nomination and Remuneration Committee. The approval is subject to shareholder approval and other required regulatory approvals under applicable laws.
2. ESOP Scheme Terms and Conditions
The Board approved the following principal terms of the ESOP Scheme:
- Total Options: 201,600 Employee Stock Options, each convertible into one equity share
- Allocation: Options to be allocated among eligible employees as per NRC recommendations
- Vesting Period: One year from date of grant, subject to fulfillment of vesting conditions
- Exercise Price: To be determined as per applicable laws and ESOP Scheme terms at time of grant
- Exercise Period: Two years from date of grant for vested options
- Vesting Conditions: Subject to continued employment/service and performance-linked conditions
- Maximum Grants: As specified in ESOP Scheme and compliant with applicable laws
- Cessation Treatment: Governed by ESOP Scheme provisions for resignation, retirement, death, permanent incapacity, termination
3. Shareholder Approval Process
The Board approved seeking member approval through a Special Resolution and authorized convening a General Meeting for this purpose. The draft Notice of General Meeting with Explanatory Statement under Section 102 of Companies Act, 2013 was also approved.
4. Authorization
Mr. Vinay Rathore, Company Secretary and Compliance Officer, was authorized to:
- Take all necessary steps for implementation
- Make requisite filings with Registrar of Companies, Stock Exchanges, SEBI, depositories
- Submit to other statutory/regulatory authorities as applicable
Meeting Details
- Meeting Duration: Commenced at 07:00 PM, concluded at 07:24 PM (24 minutes duration)
- Disclosure Date: 29 August 2026